First Trust NYSE Arca Bio... (FBT)
First Trust NYSE Arca Biotechnology Index Fund Max Pain By Strike
FBT trades at $188.53, 9.6% above the near-term max pain of $172 expiring Oct 17, 2025 (10 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($90-$172), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
First Trust NYSE Arca Biotechnology Index Fund Max Pain By Expiry
Max pain for FBT shows an upward trend from 90 to 172, suggesting bullish positioning in longer-dated options. The 68% spread signals divergent expectations across timeframes. Most levels below 188.53 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 172 | n/a (n/a) |
| Nov 21, 2025 | 140 | n/a (n/a) |
| Jan 16, 2026 | 99.22 | n/a (n/a) |
| Feb 20, 2026 | 90 | n/a (n/a) |
| May 15, 2026 | 105 | n/a (n/a) |